The RFT1 gene helps cells attach sugar chains to many proteins, which is needed for those proteins to fold correctly and do their jobs. This gene helps your body make and move these sugar building blocks inside the cell’s protein factory. If both copies of the RFT1 gene do not work properly, a person can have RFT1-CDG, a rare inherited condition that often affects brain development, muscle tone, feeding, movement, and sometimes vision. RFT1 is not a gene that is widely known in popular culture, but it is important in rare disease medicine.
What is a gene?
Genes are sections of DNA that provide cells with instructions for making molecules or directing processes in the body. Some genes hold the code for proteins, which do much of the work inside cells. Others mainly regulate when certain processes happen, where they occur, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
RFT1Gene function
What if the gene works
The RFT1 gene helps cells move sugar building blocks across the endoplasmic reticulum, a cell compartment that prepares proteins. This supports normal protein glycosylation, a sugar-tagging process that helps many proteins fold and work properly.
Risk
What if the gene does not work
Milder to more severe variants in the RFT1 gene can cause a condition that affects how cells attach sugar chains to proteins. Some children have developmental delay, muscle weakness, seizures, feeding problems, and variable vision or hearing changes.
Treatment
What does that mean for your treatment
At present, no treatment or drug choice approach linked specifically to pathogenic variants in the RFT1 gene is established. RFT1 is being studied in research on congenital disorders of glycosylation, but this has not yet led to a targeted therapy.
Conditions associated with RFT1
Gene function
What if the gene works
Inside your cells, the RFT1 gene supports an early step in protein finishing. It helps the endoplasmic reticulum, a cell compartment that prepares proteins, handle the sugar chain used to add sugar tags to many proteins. Understanding RFT1 gene function helps explain how cells get many proteins ready for normal use.
RFT1 helps move a partly built sugar chain across the membrane of the endoplasmic reticulum. This lets the cell keep building the standard sugar tag used on many newly made proteins.
After that movement step, your cells can attach the finished sugar tag to proteins as they are being prepared. This tagging helps many proteins fold into the right shape and move through the cell in an orderly way.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can affect how a gene works more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RFT1 gene can make the protein unstable or reduce its ability to move a sugar building block across the endoplasmic reticulum membrane, leaving many proteins incompletely glycosylated (missing part of their usual sugar coating). This is how variants influence the RFT1 gene's function. Milder variants may leave some activity, while more severe variants can cause a larger loss of function and are often linked to earlier or more marked features of RFT1-related congenital disorder of glycosylation.
How variants are linked to conditions
Pathogenic variants in both copies of the RFT1 gene cause RFT1 congenital disorder of glycosylation, often called RFT1-CDG. This rare inherited condition is linked to developmental delay, low muscle tone, feeding problems, seizures, and sometimes vision or hearing difficulties. When genetic testing finds disease-causing RFT1 gene variants in this pattern, it can confirm the diagnosis of RFT1-CDG.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RFT1, risk is mainly tied to family inheritance: a child is affected when they inherit two nonworking copies of the RFT1 gene, one from each parent. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change this risk. If RFT1 runs in your family, a doctor or genetic counselor can explain your personal chances more clearly.
Inheritance of RFT1 variants
RFT1-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease-causing variants in the RFT1 gene, one from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In families asking about the inheritance of RFT1 gene variants, this pattern is the well-established one.
What does my RFT1 result mean for my family?
For families with an RFT1-related condition, parents are usually healthy carriers, and brothers or sisters may also be affected or may be carriers. Close relatives on both sides of the family may carry the same gene change. Because this pattern runs in families, a confirmed RFT1 result can be useful information for relatives who are planning children or looking for an explanation for similar health problems.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to an RFT1 related condition, doctors use genetic testing for RFT1 gene variants on a blood sample, saliva, or cheek swab. A lab reads the DNA sequence and may also check for missing or extra pieces, then compares the result with known variants to help clarify whether a variant is present.
When should I consider getting a genetic test?
Consider genetic testing for the RFT1 gene if a child has signs of a rare inherited condition affecting early development, such as significant developmental delay, low muscle tone, seizures, feeding problems, or vision problems, especially when similar problems run in the family. Testing can help confirm whether changes in RFT1 are the cause.
A genetic result is only one part of your health story
Genetic results can be very informative, but what they can tell you varies based on the condition and the type of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put a person’s individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly than others, which can change how much of the medicine reaches the body and for how long. This is a common reason why the same treatment may work well for one person but less well for another, or why side effects may be more or less noticeable. Genetic differences are one part of the picture, along with age, kidney and liver function, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may work differently in different people. For many drugs, genes influence both how the body handles a medicine and how strong its effects are. This information can support more informed, personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the RFT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any concerns about medicines, side effects, or changes in your health are best discussed with your doctor.
History
In the early 2000s, researchers studying how cells build sugar chains identified the RFT1 gene through work in yeast, where it was first linked to a key step in this pathway. Building on this early work, scientists then searched for the human version of the gene and clarified its place in inherited metabolic conditions. Around 2010, reports connected pathogenic variants in the RFT1 gene with a rare congenital disorder of glycosylation, now called RFT1-CDG. That discovery helped explain why some children with similar developmental and neurologic features had previously gone without a clear diagnosis. Since then, the RFT1 gene has remained mainly important in specialist genetics and rare disease research rather than in broader public awareness.